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ABSTRACT 
Objective: The objective of this study was to evaluate the effect of a pharmacist-led intervention on self-management practices among 
hypertensive-diabetic patients receiving care in a Nigeria tertiary hospital. 
Methods: The study adopted a prospective, longitudinal; single-blind, two-arm randomised controlled trial to implement a pharmacist-led 
educational intervention on hypertension management among patients in Federal Medical Centre Lokoja, Kogi State. All the patients who met the 
eligibility criteria and gave their written consent to participate in the study were recruited into the study randomized in the intervention group (IG) 
and Control (CG). Data was collected using Hypertension Self Care Activity Level Effects (H-SCALE) questionnaire. The retrieved questionnaires 
were first coded into Microsoft Excel (2014) for cleaning of errors, after which the data was exported into the Statistical Product and Services 
Solutions (SPSS for windows, Version 16.0. SPSS Inc. 2007, Chicago, USA) software. Descriptive statistics such as frequencies, percentages and mean 
scores were used to summarise the data. All responses were first presented as frequencies and percentages. Chi-square was used to determine the 
correlation between socio-demographic and patients’ clinical characteristics. Independent sample t-test and paired sample t-test were used to 
compare differences between and within groups. 
Results: At baseline, more patients in the control group were adherent to their medications 16 (11.5) and had low salt diets 47 (33.8) than patients 
in the intervention group. However, more patients in the intervention group were non-smokers 127 (88.8) and engaged more in physical activity 38 
(26.6) than patients in the control group. However, more of the patients in the control group were adherent to weight management practices 38 
(27.3) than patients in the intervention group 36 (25.2), at baseline. All the patients in both study groups reported to have taken alcohol in the past 
seven days. It can be seen that, patients in the intervention group at endpoint, differed positively from the control group at baseline in adherence to 
medication, physical activity, reducing alcohol consumption and smoking cessation. It can also be observed that the baseline intervention group 
differed positively from the endpoint in medication adherence (t=-26.045, p<0.001); physical activity (t=-15.081, p<0.001); weight management 
practices (t=-5.479, p<0.0010, and alcohol consumption 9t=-11.550, p<0.001). 
Conclusion: A pharmacist led educational intervention had a positive impact on the self-management practices of hypertensive-diabetes patients. 
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INTRODUCTION 
The burden of hypertension and diabetes has been on the increase 
because of the increasing adult population and changes in lifestyles 
of Nigerians [1]. Studies have identified patient’s lack of knowledge 
related to self-management in terms of adherence to medications, 
and modification of lifestyle behaviours, as major factors that 
contribute to the poor control of blood pressure [2]. Self-
management practices are needed as patients try to make 
themselves healthy by exercising at least three times in a week, 
losing weight and changing their eating habit. Self-management 
practices are those activities people undertake to create order, 
discipline and control in their lives [2]. Hypertension self-care 
activities are important in the management of hypertension as 
recommended by the Joint National Committee on Prevention, 
Detection, Evaluation and Treatment of hypertension [3]. Studies 
have demonstrated the effects of self-care behaviours in the proper 
management of hypertension [4]. Medication adherence alone has 
proven not to be sufficient in the optimal management of blood 
pressure [5]. Recent studies have shown that patients who take their 
medications without engaging in dietary changes or physical activity 
have no higher rate of improved blood pressure than those who 
engaged in dietary changes and physical activities without taking 
their medications as at when due [6]. Also, studies have proved that 
adherence to hypertension self-care activities could lead to optimal 
control of blood pressure, increased efficacy of antihypertensive 
medications, reduced complications, morbidity and mortality [7]. 
The objective of this study was to evaluate the effect of a pharmacist-
led intervention on self-management practices among hypertensive-
diabetic patients receiving care in a Nigeria tertiary hospital. 
MATERIALS AND METHODS 
The study adopted a prospective, longitudinal, single-blind, two-arm 
randomized controlled trial to implement a pharmacist-led 
Educational intervention on Hypertension management and evaluate 
the effect on self-care behaviours. This section of the study was 
conducted among patients receiving care at the Federal Medical Centre 
Lokoja (FMCL). The hospital is a tertiary healthcare institution owned 
by the Federal Government of Nigeria. It offers specialized health 
services to patients from around the state, as it serves as the topmost 
referral centre for almost all the primary and secondary healthcare 
facilities within and outside the state. Ethical consideration for this 
study was obtained from the Health Research and Ethics committee, 
Federal Medical Centre Lokoja, Kogi State (Approval number: 
NHREC/05/01/2008B-FA00002458-1RB00002323). 
All the hypertensive/diabetic patients, who provided written 
consent to participate in the study and met the eligibility criteria 
were included in the study. The eligibility criteria were: Ambulatory 
patient; patients who had hypertension with only diabetes mellitus 
type II co-morbidity; patients who were aged ≥ 1 8 y and ≤ 7 0 y; 
patients who must have received at least one anti-hypertensive drug 
during the 30 d period preceding the beginning of the recruitment; 
patients who have no history of significant cardiac complications in 
the past 6 mo; patients who history of compliance with regular clinic 
visits within the last 2 y; those who are not pregnant prior to 
recruitment; patients who are able to communicate freely in English 
language and patients who gave their consent to participate. All the 
patients who met the eligibility criteria and gave their written 
consent to participate in the study were recruited into the study 
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randomised in the intervention group (IG) and Control (CG). Patients 
were recruited into the study within a one-month period during 
which their baseline characteristics were collected. At baseline, 
there was an initial assessment interview for all patients where a 
professional/therapeutic relationship was established with them. 
This initial assessment interview comprised of: a) Collection of 
patient-specific data including age, gender, occupation, religion, 
educational status, family history of hypertension, presence of co-
morbidity, income level, smoking status, alcohol consumption, 
height, weight, fasting blood sugar. b) Completion of Self-
management practices (H-SCALE) questionnaire About 3 mo after 
the baseline, a meeting was scheduled between patients in the 
intervention group and the principal investigator. At the first 
meeting (education intervention), which lasted for almost 90 min, 
the patients were taught the basic things they should know on 
medication adherence, physical activity, weight management, low 
salt diet, smoking cessation and alcohol reduction. 
About 6 mo after the baseline, a second meeting was scheduled 
between the patients in the intervention group and the principal 
investigator. The objective was to gain a firm commitment of the 
patients towards self-care and crucial lifestyle modifications. 
The pharmacist delivered an interactive presentation while 
simulating some therapeutic challenges. The features of this 
meeting also included: Agreed clear educational objectives, 
agreed clear behavioural objectives, stimulation of active 
participation, use of concise graphics, highlight and repeat 
essential messages. 
After 9 mo from baseline, a third meeting was scheduled between 
the patients in the intervention group and the principal investigator. 
The key objectives of this meeting were: Re-iterate key points 
agreed during meeting two; Enable two-way feedback, Address any 
ongoing implementation difficulties. 
The outcome measure was adherence to hypertension self-
management practices. The retrieved questionnaires were first 
coded into Microsoft Excel (2014) for cleaning of errors, after which 
the data were exported into the Statistical Product and Services 
Solutions (SPSS for windows, Version 16.0. SPSS Inc. 2007. Chicago, 
USA) software. Descriptive statistics such as frequencies, 
percentages and mean scores were used to summarise the data. All 
responses were first presented as frequencies and percentages. Chi-
square was used to determine the correlation between socio-
demographics and patients’ clinical characteristics. Independent 
sample t-test was used to compare the difference between the 
intervention group and control group, while paired sample t-test 
was used compare the difference in the intervention group at 
baseline, 3months, 6months and 9months. For all statistical analysis, 
2-tailed association was considered with the significance level set at 
p<0.05. 
RESULTS 
Socio-demographic characteristics of hypertensive patients 
Majority of the patients were aged 46-55 y in the intervention group 
and 36-45 y in the control group. There were more males than 
females in both the intervention and Control. More than half of the 
patients were self-employed and a very good number of the patients 
were civil servant. More than 99% of the patients in the intervention 
group and 97% of the patients in the control group have formal 
education. About half of the patients in the intervention and control 
group have a family history of hypertension [table 1]. 
 
Table 1: Socio-demographic characteristics of hypertensive patients N = (IG= 143; CG= 141) 






































































*FH = Family history; IG: Intervention group; CG: Control group 
 
Table 2: Hypertension self-care activity level effects (H-Scale) of patients at baseline 
Domain IG N= 143 CG N= 139 
Adherent n (%) Non-adherent n (%) Adherent n (%) Non-adherent n (%) 
Medication adherence 8 (5.6) 135 (94.4) 16 (11.5) 123 (88.5) 
Low salt diet 44 (30.8) 99 (69.2) 47 (33.8) 92 (66.2) 
Smoking 127 (88.8) 16 (11.2) 118 (84.9) 21 (15.1) 
Physical activity 38 (26.6) 105 (73.4) 29 (20.9) 110 (79.1) 
Weight management 36 (25.2) 107 (74.8) 38 (27.3) 101 (72.7) 
Alcohol consumption 0 (0) 143 (100) 0 (0) 139 (100) 
IG = intervention group CG = Control group 
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Self-care activities of patients in the intervention and control 
groups at Baseline 
At baseline, more patients in the control group were adherent to 
their medications 16 (11.5) and had low salt diets 47 (33.8) than 
patients in the intervention group. However, more patients in the 
intervention group were non-smokers 127 (88.8) and engaged more 
in physical activity 38 (26.6) than patients in the control group. 
More of the patients in the control group were adherent to weight 
management practices 38 (27.3) than patients in the intervention 
group 36 (25.2). All the patients in both study group reported to 
have taken alcohol in the past seven days [table 2]. 
Self-Care activities at 9 mo post-intervention 
From table 3, the intervention group reported more adherence in 
their medications 106 (96.4) than patients in the control group 38 
(39.2). It was observed that about 97 (88.2%) of the patients in the 
intervention group were adherent to low salt diets while only 11 
(11.3) of the patients in the control group were adherent to low salt 
diets. While none of the patients in the control group reported to be 
physically active, about 107 (97.3) patients in the intervention group 
reported that they were physically active in the past seven days. Also 
a majority of the patients in the intervention group 72 (65.5) were 
adherent to weight management practices unlike patients in the 
control group 26 (26.8). More patients in the intervention group 
reduced their alcohol consumption 46 (41.8) when compared to 
patients in the control group 12 (12.4). 
From table 4, it can be seen that the intervention group at the 
endpoint differed from the control group at baseline in adherence to 
medication, physical activity, reducing alcohol consumption and 
smoking cessation. 
 
Table 3: Hypertension self-care activity level effects (H-Scale) of patients at 9 mo 
Domain IG N= 110 CG N= 97 
Adherent n (%) Non-adherent n (%) Adherent n (%) Non-adherent n (%) 
Medication adherence 106 (96.4) 4 (3.6) 38 (39.2) 59 (60.8) 
Low salt diet 97 (88.2) 13 (11.8) 11 (11.3) 86 (88.7) 
Smoking 105 (95.5) 5 (5.5) 83 (85.6) 14 (14.4) 
Physical activity 107 (97.3) 3 (2.7) 0 (0) 97 (100) 
Weight management 72 (65.5) 38 (34.5) 26 (26.8) 71 (73.2) 
Alcohol consumption 46 (41.8) 64 (58.2) 12 (12.4) 85 (87.6) 
IG = intervention group CG = control group 
 
Table 4: Independent sample t-test for H-scale of intervention group endpoint and control group baseline 
 Mean (SD) t p-value 
Medication adherence 0.848 (0.035) 24.111 <0.001* 
Low salt diet -0.0500 (0.060) -0.832 0.406 
Physical activity 0.767 (0.042) 18.320 <0.001* 
Weight management 0.064 (0.060) 1.079 0.282 
Alcohol consumption 0.562 (0.042) 13.345 <0.001* 
Smoking -0.112 (0.039) -0.290 0.004 
*p significant at<0.05 
 
Table 5: Change in H-SCALE at Baseline, 3 mo and 9 mo in the intervention group 
H-SCALE 
 
Baseline and 9 mo 3 mo and 9 mo 6 mo and 9 mo 
Mean 
difference 
t p-value Mean 
difference 
t p-value Mean 
difference 
t p-value 
Medication adherence -0.886 (0.348) -26.045 <0.001* -0.324 (0.509) -6.513 <0.001* -0.124 (0.385) -3.298 0.001* 
Low salt diet 0.038 (0.619) 0.631 0.530 0.019 (0.511) 0.342 0.733 0.010 (0.656) 0.148 0.882 
Physical activity -0.705 (0.479) -15.081 <0.001* -0.114 (0.320) -3.663 <0.001* 0.000 (0.196) 0.000 1.000 
Weight management -0.257 (0.481) -5.479 <0.001* -0.034 (0.538) -0.598 0.552 -0.191 (0.480) -0.407 0.685 
Alcohol consumption -0.562 (0.499) -11.550 <0.001* 0.356 (0.549) 6.050 <0.001* 0.190 (0.482) 4.047 <0.001 
Smoking 0.067 (0.347) -1.968 0.052 -0.019 (0.195) -1.000 0.320 -0.010 (0.259) -0.376 0.707 
From table 5, it can be observed that the baseline intervention group differed from the endpoint in medication adherence t=-26.045, p<0.001; 
physical activity t=-15.081, p<0.001; weight management practices t=-5.479, p<0.001 and alcohol consumption t=-11.550, p<0.001 
 
DISCUSSION 
In this study, physical activity was increased by 70.5%, whereas there 
was 25.7% increase in the weight management practices engaged by 
these hypertensive/diabetic patients. Although patients reduced their 
intake of salt diets by 3.8%, there was a 56.2% increase in their alcohol 
consumption. Patients in the intervention group reduced their 
smoking by 6.7%. Reduced salt consumption has been associated with 
a decrease in blood pressure [8]. The amount of salt recommended by 
the 2007 WHO guideline is 5g/daily [9]. A systematic review of 
randomised controlled trials has proved that a reduction in salt intake 
reduced blood pressure in adults who have or do not have 
hypertension [10]. An increase in salt intake as a matter of fact, have 
been associated with the risk of developing cardiovascular diseases 
and stroke [11]. On the contrary, recent studies have expressed 
concern that reduced sodium intake can lead to an adverse effect on 
health like unhealthy changes in blood lipids and renal function [12]. 
Exercise has been found to potentially reduce SBP in hypertensive 
patients [13]. Physical inactivity has been identified as an important 
modifiable risk factor in the development of hypertension [14]. It has 
been observed that exercise can lead to as much as 5-7 mmHg 
reduction in both the SBP and DBP [15]. More frequent exercise can 
lead to a sustained reduction in blood pressure [16]. Furthermore, 
hypertensive patients who smoke are more likely to develop severe 
forms of hypertension including malignant and renovascular 
hypertension [17]. In a study to determine the association between 
smoking and blood pressure, it was observed that there were no 
significant dose-dependent effects of smoking on blood pressure 
indices [18]. While some studies show a positive relationship between 
smoking and blood pressure [19], other studies have shown that there 
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is an inverse association between smoking and blood pressure [20]. 
However, evidence has shown that smoking causes direct endothelial 
damage, which could lead to endothelial dysfunction and impairment 
of endothelium-dependent coronary vasodilatation [21]. It is because 
smoking produces a significant change in forearm hemodynamic 
affecting both small and large arteries [22], that probably, it could be 
important in the pathophysiology of hypertension. 
Limitations of the study 
It is evident that the described pharmaceutical care model provides a 
significant reduction in blood pressure in the patient population 
studied. This model is applicable with site-specific modifications to a 
wide variety of practice settings, including community pharmacy, as it 
requires few resources to operate. However, some limitations of the 
study were:  
Firstly, the sustained, long-term effectiveness of this model was not 
tested. The long-term advantages of this model remain to be evaluated. 
Secondly, the study required significant efforts by the investigators 
in terms of time allocations that may preclude management of a 
large patient load. 
Thirdly, cost analysis of this intervention was not performed. 
Documentation of cost-effectiveness on a long-term basis by 
preventing costly hypertension-related complications would 
enhance the validity of such a model.  
Fourthly, a self-report measure was used to assess medication 
adherence. This could be subject to recall bias which may affect the 
precision of measurement. 
CONCLUSION 
There was an improvement in the self-management practices among 
hypertensive-diabetes patients who received a pharmacist intervention. 
Patients who received an intervention also had a significant 
improvement in their blood pressure control, blood sugar control and 
body mass index. A pharmacist-led intervention improved patient's 
adherence to their medications, physical activity and weight 
management practices.  
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